In this regard, promising results have been obtained in preclinical in vivo and in vitro studies using GH as therapy for Chagas disease, where the hormone was able to reduce parasitemia together with an increase in the response against the protozoan and reduced infection of the myocardial tissue (35, 135). The gene discussed is GH1; the disease is infection.